Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of KLC1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of KLC1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of KLC1 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of KLC1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KLC1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of KLC1 mRNA | decreases expression | 19654921
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLC1 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A affects the expression of KLC1 mRNA | affects expression | 14967926
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of KLC1 mRNA | increases expression | 20106945
|
D004040 |
Dietary Carbohydrates |
Dietary Carbohydrates results in decreased expression of KLC1 mRNA | decreases expression | 17490981
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of KLC1 mRNA | decreases expression | 18035473
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of KLC1 mRNA | decreases expression | 18797397
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of KLC1 mRNA | increases expression | 16849584
|
C076029 |
olanzapine |
olanzapine results in decreased expression of KLC1 mRNA | decreases expression | 18797397
|
C025299 |
polyphenols |
polyphenols results in decreased expression of KLC1 mRNA | decreases expression | 16293270
|
C009277 |
sodium arsenate |
sodium arsenate results in increased expression of KLC1 mRNA | increases expression | 16882884
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of KLC1 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
3.94 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.21 | 17306315 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.86 | 16251483 16835338 12569548 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.24 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.38 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.38 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.38 | 18685284 17069543 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.84 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.48 | 17123778 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.92 | 16050911 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.58 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.54 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.54 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.54 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
6.54 | 17306315 16507464 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.98 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.68 | 17687452 15504454 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.06 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.43 | 15738583 17938729 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.29 | 16973168 18022660 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.90 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.38 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.38 | 10977129 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.25 | 18071103 16772815 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.05 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.05 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.90 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.67 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.14 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
3.01 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.01 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.85 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.85 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.82 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.56 | 11575062 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.68 | 17069543 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
15.21 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.21 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
15.21 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
15.21 | 19370779 16177239 19164858 17522070 19420014 15968718 14550746 19085960 12153990 11421492 14725611 14986274 19923254 12958197 15619225 17906064 16781746 16109766 2444490 11287661 10663392 12705907 16393943 11834606 17562736 18071297 10774834 16227642 11739529 10915739 12540782 16081117 11529661 12594235 16485898 19739265 11743745 11461765 12392966 19416960 18713872 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
15.21 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
15.21 | 18186108 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.70 | 9068938 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.84 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.13 | 12639820 12168785 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.56 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.06 | 19446573 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
2.98 | 16080930 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.69 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.97 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.68 | 16870215 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.44 | 17050553 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.22 | 17933447 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.27 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.27 | 10903974 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.56 | 16093927 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.40 | 17296493 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.40 | 16366677 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.21 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.27 | 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.98 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.93 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.93 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.93 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.26 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.26 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.26 | 12371664 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.54 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.60 | 12969438 16611625 19784758 12587719 19014921 19460945 11587558 16610002 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.60 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
6.60 | 16698588 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.22 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.70 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
4.70 | 16368122 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.53 | 6135515 2876784 2876786 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.71 | 20210726 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.16 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.65 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.65 | 11062179 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
8.59 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
8.59 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.37 | 19142110 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.84 | 18186108 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
3.96 | 15371236 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.32 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.32 | 7678174 18551238 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
3.96 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.71 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
7.71 | 18186108 10525206 11749123 19446573 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.85 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.36 | 17056641 |
MESH:D009765 |
Obesity |
|
olanzapine |
3.71 | 18515891 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.05 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.05 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.05 | 14694615 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.98 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.74 | 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.37 | 16870215 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.16 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.98 | 15371236 6392382 16905509 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.94 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.19 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.66 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.66 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.66 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.99 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
11.77 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
11.77 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
4.24 | 11575062 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.78 | 10548101 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
4.34 | 18513383 19369910 20107430 1830565 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
4.34 | 20521326 17726453 20107430 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.82 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.82 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
5.02 | 19834688 17050553 18709164 17548696 16759981 17453740 15952646 16353154 16702368 6392382 17938729 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
5.02 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
3.00 | 17976673 19538983 17029826 15504454 17050553 16251483 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.50 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.97 | 16684133 16045194 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
10.90 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
10.90 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.25 | 17997062 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.30 | 17976673 17306315 11144890 18640142 19322015 19429237 15987713 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.96 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.96 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.01 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.73 | 17056641 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
5.14 | 19434072 17933447 20107430 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |